Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of nicotinic receptor modulators. Its structure supports the creation of bioactive molecules targeting neurological disorders such as depression, anxiety, and cognitive dysfunction. Commonly employed in medicinal chemistry for constructing cyclopropane-containing analogs that enhance metabolic stability and binding affinity. Also utilized in research settings to explore structure-activity relationships in pyridine-based drug candidates.